|
The Medical Oncology Training
Program of Queen's University is an accredited program through
Queen's University and
managed through the Cancer
Centre at Kingston General
Hospital (KGH).
The members of the program believe in participation in research
and educational activities. The Medical Oncology Training
Program provides excellent training to residents through involvement
in the clinical program, participation in educational activities
such as tumour boards, conferences, academic half days and
involvement with the Queen's
Cancer Research Institute (QCRI).
Site-specific multidisciplinary
teams, which include medical oncologists and radiation oncologists
work together with surgeons, pathologists, radiologists and
other health care professionals to provide state-of-the-art
medical care.
The Centre functions in a Site-specific multi-disciplinary
structure with both Medical and Radiation Oncologists, Hematologists,
Pathologists, Surgeons, Internists and other health care professionals
to ensure the absolute best medical care. In addition, there
is a large support team including Supportive Care Providers,
Psychologists, Social Workers, Dieticians, among others. The
in-patient facility is through the Kingston General Hospital.
The Medical Oncology Training
Program supports the objectives of the Royal College, and
the program is structured to follow CanMEDS. The overall goal
of the program is to train residents to be successful, well-qualified
Medical Oncologists, fulfilled in their clinical and/or research
careers.
TOP
EDUCATIONAL
PROGRAM
The two-year program is structured
to meet the objectives and specialty training requirements
in Medical Oncology established by the Royal
College of Physicians and Surgeons of Canada (RCPSC) and
to allow eligibility for the examination leading to the Certificate
of Special Competence in Medical Oncology.
TOP
PROGRAM
STRUCTURE
Dr. Anna Tomiak
is the Director of the Medical Oncology Training Program.
The Training Program Committee is comprised of representatives
from Medical Oncology, Radiation Oncology, Haematology-Oncology
and Clinical Trials. The Committee meets once every 2 months.
Resident input is always discussed at these meetings. Issues
affecting the program and residents, information from the
Royal College or Post-graduate Dean’s office are also
discussed. Resident evaluations are reviewed. The Committee
is responsible for ensuring that Residents are adequately
prepared for the Royal College examinations. The Committee
is responsible for the Final In-Training Evaluation.
Training Program Committee Members:
Dr. Anna Tomiak - Program
Director
Dr. Tara Baetz- Medical Oncology
Dr. Mihaela Mates- Medical Oncology
Dr. Maria Kalyvas- Radiation Oncology
Dr. David Lee - Haematology-Oncology
Dr. Wendy Parulekar- Medical Oncology/NCIC-CTG
Dr. Abdullah Al Sharm, Resident
Micheline Primeau
- Program Coordinator
Year One
The first year of the training program consists of core oncology
rotations including:
- Medical Oncology
- Hematology (3 blocks)
- Radiation Oncology (3 blocks)
The majority of the clinical
experience in medical oncology takes place in the outpatient
setting. Residents are assigned to tumour specific sites and
spend 2-3 month rotations attending and participating in these
clinics during the first year. Residents are also be involved
in providing in-patient consultation services according to
the site-specific rotation.
Year Two
The second year of training includes:
- Medical Oncology
- In-patient rotations (2
-3 blocks)
- Palliative Care (1 block)
- Research and other electives
(5 blocks)
During the in-patient rotations,
the resident acts as a Junior Consultant on the ward working
with internal medicine house staff and with attending staff
back up.
The scheduled rotations provide
the trainee with the opportunity to gain experience in all
aspects of the practice of medical oncology and to interact
with complimentary disciples including radiation, hematology,
gynecology and surgical oncology, ENT, infectious disease
and palliative care. The close affiliation and good working
relationship with the host hospital ensures interaction and
collaboration with internal medicine, surgical and radiology
specialties.
Year Three
The Medical Oncology Division also offers a 3 year Medical
Oncology Training Program to those interested in obtaining
additional clinical research experience. This is based on
the core 2 year program required by the RCPSC with a third
year including coursework in clinical epidemiology and an
opportunity to gain clinical trial experience with the NCIC Clinical Trials Group (NCIC-CTG).
This third fellowship year allows residents to work directly
with researchers at the NCIC-CTG and become involved in different
stages of clinical trial development from trial design to
data collection and analysis. This is a unique opportunity
for trainees to work with an internationally recognized research
organization and to gain practical experience in the conduct
of Phase I, II and III clinical trials.
Numerous educational opportunities
are available for residents. A weekly formal teaching session
is mandatory and residents are relieved of clinical responsibilities
during this time.
Standard topics including specific disease site information,
pharmacology, basic science, bio-statistics, ethics, palliative
and psychosocial aspects of care are covered. Joint sessions
with radiation and hematology oncology residents are provided.
Participation in multidisciplinary rounds, grand rounds and
journal clubs is expected.
Residents are expected to complete a research project during
their two years of training. Guidance is provided to help
in the selection of an appropriate project. Liaison with mentors
from Queen's Cancer
Research Institute is available to assist with development
and execution of research ideas.
TOP
RESEARCH
The program is committed to
providing an excellent research experience for residents.
A research mentor is assigned to residents on entry into the
program and residents are expected to have at least one research
project underway by the second year.
One of the strong assets of
the research component of the program is access to several
internationally renowned cancer research groups based at Queen's.
Several members of these groups are also members of the Medical
Oncology department. The newly created Cancer Research Institute
(CRI) brings together three of these internationally recognized
groups: Queen's Cancer Research Laboratories), NCIC Clinical Trials Group (NCIC-CTG) and the Cancer
Care and Epidemiology (formerly Radiation Oncology Research
Unit). The new institute is the home to approximately 250
senior investigators, professional trainees and technical
support and research staff.
Residents are encouraged to participate in the clinical research
activities/meetings of the NCIC-CTG. This Queen's University
based group is internationally recognized for its expertise
in the design, conduct and analysis of Phase I, II and III
clinical studies. They have extensive experience in research
pertaining to quality of life, clinical trials methodology
and the economic analysis of cancer therapies. Members of
this group participate in the clinical and educational activities
of the Cancer Centre and are a willing resource for residents.
TOP
ELIGIBILITY
REQUIREMENTS
Candidates must have completed
three years of a RCPSC accredited program in Internal Medicine.
International
medical graduates may be considered on an individual basis.
Please visit the Queen's
Post-Graduate Medical Education web site for details regarding
the application process.
TOP
APPLICATIONS
Effective 2009, Queen's University now participates in the Canadian Residency Matching Systems (CaRMS). Applications for the 2010
academic year are currently being accepted through the CaRMS website.
Interviews will be
conducted on at the Cancer Centre of SE Ontario on
**Tuesday, October 19th, 2010**
If a match for the available position(s) is not successful, we will consider applications from non-Canadian trained residents providing all eligibility criteria is met.
Should you have any additional
questions about the program, please contact Micheline
Primeau.
TOP
|
